文献速递乳腺癌支持与姑息治疗

智能手机心理治疗降低乳腺癌幸存者对癌症复发的恐惧:一项完全去中心化随机对照临床试验(J-SUPPORT 1703研究)

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study).
PubMed 文献 · J Clin Oncol · 2022-11-02

该去中心化随机对照试验纳入无病乳腺癌幸存者(20-49岁),比较智能手机问题解决疗法与行为激活应用联合常规治疗与等待名单对照联合常规治疗的疗效。主要终点为第8周复发担忧量表,干预组在复发担忧量表、恐惧癌症复发量表简版、医院焦虑抑郁量表抑郁维度及支持性照护需求调查心理领域均较对照组有统计学显著改善。第24周时上述 scores 与第8周相比无统计学显著差异,但医院焦虑抑郁量表抑郁评分在第24周显著降低。

要点

  • 智能手机心理治疗在第8周显著改善乳腺癌幸存者的复发恐惧、恐惧癌症复发量表简版、抑郁及心理需求。
  • 第24周时多数结局与第8周相比无统计学显著差异,但抑郁评分在第24周显著降低。
  • 该去中心化干预模式有望在治疗师有限的情况下扩大心理治疗的可及性。

核心结论

  • 新型智能手机心理治疗为减少复发恐惧提供了有前景的方式,尤其考虑到幸存者数量大而能胜任心理治疗的治疗师有限。

研究设计与样本

  • 完全去中心化的随机对照试验,纳入无病乳腺癌幸存者,年龄20-49岁,随机分配至智能手机干预组或等待名单对照组,两组均接受常规治疗。
  • 干预组223人,对照组224人;主要终点第8周获得444例数据,干预组213人完成第24周评估。
  • 对照组可在第8-24周访问智能手机应用;干预包括智能手机问题解决疗法和行为激活应用。

主要发现

  • 第8周干预组复发担忧量表改善优于对照组,差异-1.39(95% CI,-1.93至-0.85;P < .001)。
  • 第8周干预组恐惧癌症复发量表简版改善优于对照组,差异-1.65(95% CI,-2.41至-0.89;P < .001)。
  • 第8周干预组医院焦虑抑郁量表抑郁维度改善优于对照组,差异-0.49(95% CI,-0.98至0;P < .05)。
  • 第8周干预组支持性照护需求调查心理领域改善优于对照组,差异-1.49(95% CI,-2.67至-0.32;P < .05)。
  • 第24周上述 scores 与第8周相比无统计学显著差异,但医院焦虑抑郁量表抑郁评分在第24周显著降低(P = .03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fear of cancer recurrence (FCR) is a common distressing condition. We investigated the efficacy of smartphone problem-solving therapy and behavioral activation applications in breast cancer survivors. METHODS: This was a decentralized randomized trial. Participants were disease-free breast cancer survivors age 20-49 years who were randomly assigned to the smartphone-based intervention or waitlist control. Both groups received treatment as usual. The control group could access the smartphone apps during weeks 8-24. The intervention comprised smartphone problem-solving therapy and behavioral activation apps. The primary end point was the Concerns About Recurrence Scale at week 8. Secondary outcomes included the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF), the Hospital Anxiety and Depression Scale (HADS), the Short-form Supportive Care Needs Survey (SCNS-SF34), and the Posttraumatic Growth Inventory at weeks 8 and 24 (trial registration: UMIN-CTR: UMIN000031140). RESULTS: The intervention group included 223 participants, and the control group included 224 participants. Primary outcome data were obtained for 444 participants, and 213 participants in the intervention arm completed the week 24 assessment. The intervention group had statistically greater improvements than controls at week 8 on the Concerns About Recurrence Scale (difference -1.39; 95% CI, -1.93 to -0.85; P < .001), FCRI-SF (difference -1.65; 95% CI, -2.41 to -0.89; P < .001), HADS depression (difference -0.49; 95% CI, -0.98 to 0; P < .05), and SCNS-SF34 psychological domain (difference -1.49; 95% CI, -2.67 to -0.32; P < .05). These scores at week 24 were not statistically significant compared with week 8 although the HADS depression score at week 24 was significantly reduced (P = .03). CONCLUSION: Novel smartphone psychotherapy offers a promising way to reduce FCR given the large number of survivors and a limited number of therapists to competently conduct psychotherapy.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Akechi T, Yamaguchi T, Uchida M, et al. Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). J Clin Oncol. 2022. PMID: 36322882. doi:10.1200/JCO.22.00699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。